Pompella et al, 2003 describe a number of signalling cascades affected by protein S-glutathionylation: NF-kB/p50 (Pineda-Molina et al., 2001) and PTP1B phosphatase (Barrett et al., 1999), for example, which are able to affect cell proliferation
Staying hydrated and following post-treatment guidelines can help minimize these effects
Pharmacogenetics of treatment response in psoriatic arthritis
Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Customized Treatment Options : Each patients treatment is fully tailored to help them address their concerns and achieve their goals